Trainings and Resources

This study looks at how common the presence of alcohol is in opioid overdose deaths. While there are "waves" of the opioid crisis, the authors studied how alcohol affect individuals in this fourth wave as it is characterized by opioid-stimulant polysubstance use.

The National Survey on Drug Use and Health (NSDUH) is conducted annual and provides nationally representative data on the use of substances (tobacco, alcohol, and drugs), substance use disorders, those who received substance use treatment, and mental health issues and services. This survey is conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA).

These guides from the Substance Abuse and Mental Health Services Administration (SAMHSA) highlights strategies for behavioral health and housing providers to conduct outreach and engage with individuals experiencing homelessness, initiate use of behavioral health treatment as they wait to receive stable housing and retain them in their recovery efforts once housed.

There are systemic barriers in hospital-based addiction medicine that can lead to symptoms of burnout among medical professionals. The qualitative study highlights these factors that may contribute to burnout and provides some feedback on how to work towards minimizing this for providers.

This webinar will introduce the newest RCORP program cohorts to the RCOEs, Fletcher Group, University of Rochester, and University of Vermont. These three cooperative agreements are charged with supporting the identification, translation, dissemination, and implementation of evidence-based programs and best practices, in addition to providing specialized TA to RCORP recipients and other rural providers.

Clinicians no longer need DATA 2000 Waiver training to prescribe buprenorphine; however, the payment program to defray earlier training costs is still active.  Launched in June 2021, the initiative pays for providers who previously received a waiver to prescribe buprenorphine, a medication used to treat opioid use disorder.  Rural Health Clinics (RHCs) still have the opportunity to apply for a $3,000 payment on behalf of each provider who previously trained to obtain the waiver necessary to prescribe buprenorphine after January 1, 2019.

The Peer Recovery Support Services Mentoring Initiative (PRSSMI) is a special learning opportunity offered through the Bureau of Justice Assistance’s (BJA) Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) which supports programs, organizations, and jurisdictions interested in incorporating peer recovery support services (PRSS) into their portfolios of substance use disorder intervention and treatment strategies.  

The Consolidated Appropriations Act of 2023 removed the federal requirement for providers to have an X-waiver to prescribe medications for the treatment of OUD. The act amended the Controlled Substances Act. Depending on state law, practitioners who have a current DEA registration with Schedule III authority will be able to prescribe buprenorphine for OUD starting now.

The study found a strong association between opioid or cocaine use disorders, COVID-19, and endocarditis. Individuals with opioid or cocaine use disorders and COVID-19 had a significantly increased risk for endocarditis.

Five notices of funding opportunities (NOFOs) for grant programs was announced by the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA). The $73.4 million in total is aimed at preventing substance misuse and treating OUD and is aligned with the Biden-Harris administration's current efforts.